INS and metabolic dysfunction-associated steatotic liver disease: In addition, NAC administration also declined serum insulin levels in NAFLD-induced animals compared to those of the control groups (SMD: −2.3; 95% CI: −4.2 to −0.3 mU L-1; p-value = 0.02) (Figure 7B).